SBBP - Strongbridge Biopharma plc
Previous close
2
0 0%
Share volume: 0
Last Updated: Tue 05 Oct 2021 06:00:00 AM CEST
Pharmaceutical Preparation Manufacturing :
-2.88%
PREVIOUS CLOSE
CHG
CHG%
$2.00
0.00
0.00%
Summary score
10%
Profitability
0%
Dept financing
14%
Liquidity
42%
Performance
10%
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
Long-term ratios 30-Sep-2016 - 30-Sep-2020
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-85.65%
Return on assets
-12%
Return on sales
-386.45%
Return on invested capital
-40.97%
Total debt ratio
65.22%
Debt ratio change over timeo
-3.13%
Current Ratio
4.93%
Quick Ratio
4.84%
Cash Position Ratio
4.12%
Short-term ratios 30-Sep-2019 - 30-Sep-2020
The data are presented for the financials results of the quarters of the last year.
Return on equity
-18.38%
Return on assets
-11.39%
Return on sales
-185.87%
Return on invested capital
-99.85%
Total debt ratio
41.42%
Debt ratio change over timeo
-1.37%
Current Ratio
3.55%
Quick Ratio
3.48%
Cash Position Ratio
3.01%
Last quarter ratios 30-Sep-2020
The data are presented for the financials results of the last quarter.
Return on equity
-4.24%
Return on assets
-8.15%
Return on sales
-118.75%
Return on invested capital
-28.91%
Total debt ratio
36.62%
Debt ratio change over time
-1.26%
Current Ratio
4.51%
Quick Ratio
4.45%
Cash Position Ratio
4.22%
Performance ratios (change over 4 years) 30-Sep-2016 - 30-Sep-2020
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-260.32%
Return on assets
-64.29%
Return on sales
977.32%
Return on invested capital
-7.57%
Total debt ratio
-312.99%
Debt ratio change over time
-3.13%
Current Ratio
-12.5%
Quick Ratio
-11.03%
Cash Position Ratio
-11.15%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | SBBP | VLON | ELAT | RETA |
|---|---|---|---|---|
| Return on equity | -85.65% | 0% | 0% | 26.83% |
| Return on assets | -12% | 0% | 0% | -10.24% |
| Return on sales | -386.45% | 0% | 0% | -1670.47% |
| Return on invested capital | -40.97% | 0% | 0% | 57.71% |
| Profitability | 0% | 0% | 50% | 50% |
| Total debt ratio | 65.22% | 0% | 0% | 168.24% |
| Debt ratio change over time | -3.13% | 0% | 0% | 17.84% |
| Dept financing | 10% | 0% | 0% | 50% |
| Current Ratio | 3.55% | 0% | 0% | 8.32% |
| Quick Ratio | 3.48% | 0% | 0% | 8.32% |
| Cash Position Ratio | 3.01% | 0% | 0% | 7.97% |
| Liquididy | 70% | 0% | 0% | 74% |
| Short-term ratios | SBBP | VLON | ELAT | RETA |
|---|---|---|---|---|
| Return on equity | -18.38% | 0% | 0% | -39.65% |
| Return on assets | -11.39% | 0% | 0% | -13.45% |
| Return on sales | -185.87% | 0% | 0% | -4352.39% |
| Return on invested capital | -99.85% | 0% | 0% | 120.66% |
| Profitability | 0% | 0% | 75% | 25% |
| Total debt ratio | 41.42% | 0% | 0% | 65.53% |
| Debt ratio change over time | -1.37% | 0% | 0% | 0.08% |
| Dept financing | 16% | 0% | 0% | 50% |
| Current Ratio | 3.55% | 0% | 0% | 8.32% |
| Quick Ratio | 3.48% | 0% | 0% | 8.32% |
| Cash Position Ratio | 3.01% | 0% | 0% | 7.97% |
| Liquididy | 31% | 0% | 0% | 75% |